Soluble TNF receptors and their use in treatment of disease
View Patent ↗The present invention relates to tumor necrosis factor (TNF) antagonists and corresponding nucleic acids derived from tumor necrosis factor receptors (TNFRs) and their use in the treatment of inflammatory diseases. These proteins are soluble secreted decoy receptors that bind to TNF and prevent TNF from signaling to cells. In particular, the proteins are mammalian TNFRs that lack exon 7 and which can bind TNF and can act as a TNF antagonist.
1. An isolated nucleic acid molecule that encodes a polypeptide that consists of an amino acid sequence selected from the group consisting of: the amino acid sequence of SEQ ID NO: 10 and the amino acid sequence of amino acids 23-245 of SEQ ID NO: 10.
2. An isolated polypeptide consisting of an amino acid sequence selected from the group consisting of: SEQ ID NO:10 and the amino acid sequence of amino acids 23-435 of SEQ ID NO:10.
3. An expression vector comprising the nucleic acid molecule of claim 1 , operably linked to a regulatory sequence.
4. A cell transformed with the expression vector of claim 3 .
5. The cell of claim 4 , wherein said cell is a mammalian cell, an insect cell, or a microbial cell.
6. A process for producing a polypeptide consisting of SEQ ID NO: 10 or the amino acid sequence of amino acids 23-245 of SEQ ID NO: 10, which process comprises culturing the cell of claim 5 under conditions suitable to express said polypeptide, and recovering said polyptide.